Sentien Biotech
Mr. Miller has more than 20 years of experience in the life science industry. He previously held the roles of Head of Corporate Development at FORMA Therapeutics, a clinical stage oncology company, and Head of Business Development – Asia Pacific for Quosa, Inc., a life science informatics company. He began his biotech career at Eli Lilly and Company, where he led the identification, evaluation, and in-licensing of research informatics technologies in the Global External Research & Development group. Brian received BA degrees in Chemistry and Business from Goshen College, an MS in Health Sciences from the Harvard-MIT Division of Health Sciences Technology, and an MBA from the MIT Sloan School of Management.
This person is not in any offices
Sentien Biotech
Sentien Biotechnologies, Inc. is a privately owned, clinical-stage company developing novel approaches to cell therapy. Sentien’s mission is to harness the power of cell therapy with innovative drug delivery systems to treat a wide range of acute inflammatory diseases.